Presentation is loading. Please wait.

Presentation is loading. Please wait.

Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database  Traves D. Crabtree,

Published byMyron Davis Modified over 5 years ago

Similar presentations

Presentation on theme: "Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database  Traves D. Crabtree,"— Presentation transcript:

1 Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database  Traves D. Crabtree, MD, Andrzej S. Kosinski, PhD, Varun Puri, MD, William Burfeind, MD, Ankit Bharat, MD, G. Alexander Patterson, MD, Wayne Hofstetter, MD, Bryan F. Meyers, MD, MPH  The Annals of Thoracic Surgery  Volume 96, Issue 2, Pages (August 2013) DOI: /j.athoracsur Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Incidence of clinical T2 N0 diagnosis (diamonds) and rate of induction therapy (squares) given to patients with cT2 N0 esophageal cancer. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database  Traves D. Crabtree,"

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Comparison of Video-Assisted Thoracoscopic Surgery and Robotic Approaches for Clinical Stage I and Stage II Non-Small Cell Lung Cancer Using The Society.

Comparison of Video-Assisted Thoracoscopic Surgery and Robotic Approaches for Clinical Stage I and Stage II Non-Small Cell Lung Cancer Using The Society.
The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes  Felix G. Fernandez, MD, MS, Andrzej S. Kosinski,

The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes  Felix G. Fernandez, MD, MS, Andrzej S. Kosinski,
Andrew C. Chang, MD, Andrzej S. Kosinski, PhD, Daniel P

Andrew C. Chang, MD, Andrzej S. Kosinski, PhD, Daniel P
Endoscopic Ultrasound for Early Stage Esophageal Adenocarcinoma: Implications for Staging and Survival  Traves D. Crabtree, MD, Wael N. Yacoub, MD, Varun.

Endoscopic Ultrasound for Early Stage Esophageal Adenocarcinoma: Implications for Staging and Survival  Traves D. Crabtree, MD, Wael N. Yacoub, MD, Varun.
Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer?  Traves D. Crabtree, MD, Varun Puri,

Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer?  Traves D. Crabtree, MD, Varun Puri,
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
Ramiro Fernandez, MD, Amy Ratliff, MD, Donna Crabb, MT, Ken B

Ramiro Fernandez, MD, Amy Ratliff, MD, Donna Crabb, MT, Ken B
Diaphragmatic Defect Complicating Peritoneal Dialysis

Diaphragmatic Defect Complicating Peritoneal Dialysis
Puja Gaur, MD, Wayne L. Hofstetter, MD, B

Puja Gaur, MD, Wayne L. Hofstetter, MD, B
Defining the Optimal Treatment of Locally Advanced Esophageal Cancer: A Systematic Review and Decision Analysis  Andrew J. Graham, MD, MS, Fiona M. Shrive,

Defining the Optimal Treatment of Locally Advanced Esophageal Cancer: A Systematic Review and Decision Analysis  Andrew J. Graham, MD, MS, Fiona M. Shrive,
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy 

Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy 
Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy  Sang Kuon Lee, MD, Jongho Lee, MD  The Annals.

Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy  Sang Kuon Lee, MD, Jongho Lee, MD  The Annals.
Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections  Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.

Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections  Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.
Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer  Aalok P. Patel, BS, Traves D. Crabtree,

National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer  Aalok P. Patel, BS, Traves D. Crabtree,
FDA Perspective on Clinical Trial Design for Cardiovascular Devices

FDA Perspective on Clinical Trial Design for Cardiovascular Devices
Anthony Lemaire, MD, William R

Anthony Lemaire, MD, William R

Similar presentations

Ads by Google